Migraine Disorders

Please read these Terms of Use and Privacy Statement (collectively, the "Terms") carefully before using any of the box above indicates that you accept these Terms.

Migraine Disorders
x

Are you interested in exploring ongoing clinical trials for Migraine Disorders at the University of Alabama at Birmingham?

Yes

Following specialists treat  Migraine Disorders. Help us improve our data based on your experience.

Based on your feedback, we will add the specialty within 1 month


Submit

71%

71%

0%20%40%60%80%

Specialty scores for Migraine Disorders

Overview

If you suffer from migraine headaches, you're not alone. About 12 percent of the U.S. population gets them. Migraines are recurring attacks of moderate to severe pain. The pain is throbbing or pulsing, and is often on one side of the head. During migraines, people are very sensitive to light and sound. They may also become nauseated and vomit.

Migraine is three times more common in women than in men. Some people can tell when they are about to have a migraine because they see flashing lights or zigzag lines or they temporarily lose their vision.

Many things can trigger a migraine. These include

  • Anxiety
  • Stress
  • Lack of food or sleep
  • Exposure to light
  • Hormonal changes (in women)

Doctors used to believe migraines were linked to the opening and narrowing of blood vessels in the head. Now they believe the cause is related to genes that control the activity of some brain cells. Medicines can help prevent migraine attacks or help relieve symptoms of attacks when they happen. For many people, treatments to relieve stress can also help.

NIH: National Institute of Neurological Disorders and Stroke

FDA Approved Medicines

  • FDA approved sumatriptan, sold as Imitrex, manufactured by GlaxoSmithKline for the treatment of migraine headaches ( Migraine Disorders ) in year 1997.
  • FDA approved divalproex sodium, sold as Depakote ER, manufactured by Abbott Laboratories for the prophylaxis (prevention) of migraine headaches in adults ( Migraine Disorders ) in year 2000.
  • FDA approved valproic acid delayed release, sold as Stavzor, manufactured by Banner Pharmacaps for the treatment of bipolar manic disorder, seizures and migraine headaches ( Bipolar Disorder | Migraine Disorders | Seizures ) in year 2008.
  • FDA approved almotriptan malate, sold as Axert, manufactured by Pharmacia & Upjohn for the treatment of migraine attacks ( Migraine Disorders ) in year 2001.
  • FDA approved frovatriptan succinate, sold as Frova, manufactured by Elan Pharmaceuticals as tablets for the acute treatment of migraine attacks ( Migraine Disorders ) in year 2001.
  • FDA approved eletriptan hydrobromide, sold as Relpax, manufactured by Pfizer for the acute treatment of migraine headaches ( Migraine Disorders ) in year 2002.
  • FDA approved zolmitriptan, sold as Zomig, manufactured by AstraZeneca as orally disintegrating tablet for the treatment of acute migraine in adults ( Migraine Disorders ) in year 2001.
  • FDA approved diclofenac potassium for oral solution, sold as Cambia, manufactured by Kowa Pharmaceuticals for the treatment of migraine attacks ( Migraine Disorders ) in year 2009.